Both in Pharmaceuticals
Ovid Therapeutics vs PUMA BIOTECHNOLOGY
Over the past year OVID returned +30.3% and PBYI returned +80.4%; their daily moves had a correlation of 0.14.
OVID +30.3% PBYI +80.4%Growth of $1, one year, split-adjusted
| Metric | OVID | PBYI |
|---|---|---|
| Price | $2.15 | $9.83 |
| Market cap | $419.9M | $507.4M |
| Today | −4.87% | −6.56% |
| 1 month | −20.4% | +3.3% |
| 6 months | −26.1% | +31.6% |
| Year to date | +31.9% | +65.2% |
| 1 year | +30.3% | +78.7% |
| Revenue growth (YoY) | −88.3% | +7.8% |
| Gross margin | 100.0% | 77.9% |
| Net margin | −2047.6% | 14.5% |
| P/E (TTM) | — | 19.0× |
| Price / sales | 265.2× | 2.2× |
| Net cash | $117.2M | $93.9M |
| Dividend yield | — | — |
| Volatility (60d) | 53.1% | 41.5% |
| Short % of float | 12.0% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).